Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CAVA Group, Inc.(CAVA) | 9,507,990 | 9,507,990 | 0 | $821.59M | $800.86M | 86.09% | -$20.73M |
| Lexicon Pharmaceuticals, Inc.(LXRX) | 136,180,481 | 136,180,481 | 0 | $62.64M | $129.37M | 13.91% | +$66.73M |